Waldenstrom Macroglobulinemia

Showing NaN - NaN of 17

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

B-cell Malignancies Undergoing Treatment With Bruton Tyrosine

Not yet recruiting
  • Chronic Lymphocytic Leukemia
  • +4 more
  • Non-Interventional Study
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Nov 22, 2023

Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Follicular Lymphoma Trial in United States (Zilovertamab vedotin)

Active, not recruiting
  • Chronic Lymphocytic Leukemia
  • +11 more
  • Zilovertamab vedotin
  • Duarte, California
  • +13 more
Jan 12, 2023

Waldenstrom Macroglobulinemia, Multiple Myeloma, Chronic Lymphocytic Leukemia Trial in Worldwide (Iopofosine I 131 single dose,

Recruiting
  • Waldenstrom Macroglobulinemia
  • +8 more
  • Iopofosine I 131 single dose
  • +2 more
  • Redlands, California
  • +42 more
Dec 30, 2022

Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Lymphocytic, Small, Lymphoma, Mantle-Cell Trial in Worldwide (Pirtobrutinib)

Available
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • +4 more
  • Stanford, California
  • +61 more
Aug 17, 2022

Asymptomatic COVID-19 Infection Laboratory-Confirmed, B-Cell Tumor, Chronic Lymphocytic Leukemia Trial in Rochester (Ibrutinib,

Withdrawn
  • Asymptomatic COVID-19 Infection Laboratory-Confirmed
  • +8 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Aug 2, 2022

Lymphoplasmacytic Lymphoma, Waldenstrom Macroglobulinemia Trial in United States (Ibrutinib, Rituximab, Venetoclax)

Suspended
  • Lymphoplasmacytic Lymphoma
  • Waldenstrom Macroglobulinemia
  • Centralia, Illinois
  • +73 more
Jul 27, 2022

Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma Trial in

Completed
  • Adult Nasal Type Extranodal NK/T-cell Lymphoma
  • +20 more
  • Scottsdale, Arizona
  • +1 more
May 6, 2022

Multiple Myeloma, Waldenstrom Macroglobulinemia Trial in United States (oprozomib)

Terminated
  • Multiple Myeloma
  • Waldenstrom Macroglobulinemia
  • Scottsdale, Arizona
  • +18 more
Nov 15, 2021

Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Chronic Lymphocytic Leukemia, Recurrent Extranodal Marginal Zone Lymphoma of

Active, not recruiting
  • Recurrent B-Cell Non-Hodgkin Lymphoma
  • +22 more
  • Scottsdale, Arizona
  • +1 more
Aug 10, 2021

Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma Trial in

Completed
  • Adult Nasal Type Extranodal NK/T-cell Lymphoma
  • +18 more
  • Scottsdale, Arizona
  • +1 more
Sep 28, 2020

B-cell Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Diffuse Well-differentiated Lymphocytic Lymphoma Trial in

Completed
  • B-cell Chronic Lymphocytic Leukemia
  • +9 more
  • Stanford, California
  • +15 more
May 14, 2020

B Cell Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, Waldenstrom Macroglobulinemia Trial in United States (AVL-292)

Completed
  • B Cell Non-Hodgkin's Lymphoma
  • +2 more
  • Huntsville, Alabama
  • +12 more
Nov 6, 2019

Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue, Nodal Marginal Zone Lymphoma, Recurrent Grade 1

Completed
  • Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue
  • +8 more
  • Scottsdale, Arizona
  • +1 more
Apr 4, 2019

MALT, Nodal Marginal Zone B-cell Lymphoma, Recurrent Grade 1 Follicular Lymphoma Trial in Rochester (rituximab, yttrium Y 90

Terminated
  • Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue
  • +8 more
  • rituximab
  • +4 more
  • Rochester, Minnesota
    Mayo Clinic
Jul 9, 2018

Adult DLBCL, Mantle Cell Lymphoma Recurrent, Lymphoma, Follicular Trial in Rochester (Doxycycline)

Terminated
  • Adult Diffuse Large B-Cell Lymphoma
  • +8 more
  • Rochester, New York
    University of Rochester
Oct 27, 2016

Waldenström Macroglobulinemia Trial in United States (oblimersen sodium)

Completed
  • Waldenström Macroglobulinemia
  • oblimersen sodium
  • Scottsdale, Arizona
  • +7 more
Jun 3, 2013